论文部分内容阅读
AIM To examined the efficacy and safety of treatmentwith boceprevir, PEGylated-interferon and ribavirin (PR)in hepatitis C virus genotype 1 (HCVGT1) PR treatmentfailuresin Asia.METHODS: The Boceprevir Named-Patient Programprovided boceprevir to HCVGT1 PR